Fen-Phen / Redux Index
November 1999 through October 2000
Volume 3, Issues 1-12

How to use this index:

• Each category appears in capital letters, followed by case names or subheadings.

• Issue and page numbers are listed after each intry indicating where articles appear.

• A capital letter following a page number indicates the section of a given issue which contains a related document.

• An asterisk (*) following a page number indicates a document available via fax through Mealey’s Document Service. These documents were not published in the Report due to space limitations. For ordering information, refer to the last page of this index.

• A pound sign (#) following a page number indicates a specially priced document available only through Mealey’s Customer Service at (610) 768-7800.

• The final section of this index – Case Name and Supplemental Document List – provides an alphabetical listing of every case included in the index and document numbers for those documents that were not reprinted in the Report due to space limitations.

For example:

Iss. 12, 6/12/93, p5B

• An article appears in Issue 12, Page 5 (dated June 12, 1993)
• An accompanying document is printed in Section B of that issue.

Iss. 11, 6/5/93, p8*

• An article appears in Issue 11, page 8 (dated June 5, 1993.)
• A document is available through Mealey’s Document Service.

Opinion: 27-950069-011

(only in Case List & Supplemental Document section)

• A document is available through Mealey’s Document Service
• The document number is 27-950069-011

Need Help?

If you can’t find what you’re looking for, just call us at (610) 768-7800. Mealey’s Customer Service Department is available to help you.

GUIDE TO ISSUE NUMBERS AND PUBLICATION DATES

ISSUE DATE

#1 ………………………….. November 1999

#2 ………………………….. December 1999

#3 ………………………….. January 2000

#4 ………………………….. February 2000

#5 ………………………….. March 2000

#6 ………………………….. April 2000

#7 ………………………….. May 2000

#8 ………………………….. June 2000

#9 ………………………….. July 2000

#10 ………………………… August 2000

#11 ………………………… September 2000

#12 ………………………… October 2000

SECTION I:

SUBJECT INDEX

ACCELERATED IMPLEMENTATION OPTION (AIO)

336,344 responses received for settlement, Iss. 10, Aug. 2000, p12

Brown, Sheila et al. v. American Home Products, Iss. 1, Nov. 1999, p3A*; Iss. 7, May 2000, p10; Iss. 8, June 2000, p4; Iss. 8, June 2000, p11A,B*; Iss. 8, June 2000, p12; Iss. 8, June 2000, p13; Iss. 9, July 2000, p12; Iss. 10, Aug. 2000, p7B; Iss. 11, Sept. 2000, p4A

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 7, May 2000, p10; Iss. 7, May 2000, p24*; Iss. 8, June 2000, p4; Iss. 8, June 2000, p11A,B*; Iss. 8, June 2000, p12; Iss. 8, June 2000, p13; Iss. 9, July 2000, p12; Iss. 10, Aug. 2000, p7B; Iss. 11, Sept. 2000, p4A

Proponents, opponents debate trial viability, settlement adequacy, Iss. 1, Nov. 1999, p11

ACTUAL MALICE

Lamping, Teri et al. v. American Home Products Corp., et al., Iss. 10, Aug. 2000, p4K

ADVERSE DRUG EVENTS

AHP: Federal grand jury subpoenas documents about adverse events, Iss. 7, May 2000, p23

In Re: American Home Products Corp., Iss. 4, Feb. 2000, p17

Collins, Eileen S. et al. v. American Home Products Corp., et al., Iss. 5, March 2000, p17C

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 1, Nov. 1999, p18E; Iss. 1, Nov. 1999, p19D: Iss. 1, Nov. 1999, p20*; Iss. 5, March 2000, p17C

Dignan, JoAnne v. Gate Pharmaceuticals Inc., et al., Iss. 1, Nov. 1999, p20*

Hawthorne, Adelia v. American Home Products Corp., et al., Iss. 10, Aug. 2000, p3C

Kerr, Berle Dee et al. v. Wyeth-Ayerst Laboratories et al., Iss. 5, March 2000, p5

Oran, Albert et al. v. John R. Stafford, et al., Iss. 11, Sept. 2000, p19*

ADVISORIES / RECOMMENDATIONS / STUDIES / TESTS

3 new medical studies indicate valve damage may regress or not worsen, Iss. 2, Dec. 1999, p18

AHP: Study says aortic ‘regurg’ unchanged, may improve; mitral unchanged, Iss. 9, July 2000, p19

Brown, Shiela et al. v. American Home Products, Iss. 3, Jan. 2000, p10E,F

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 1, Nov. 1999, p18E; Iss. 1, Nov. 1999, p19D: Iss. 1, Nov. 1999, p20*; Iss. 3, Jan. 2000, p10E,F; Iss. 10, Aug. 2000, p15G,H

Dexfenfluramine elevates blood pressure, study says, Iss. 5, March 2000, p20

Dignan, JoAnne v. Gate Pharmaceuticals Inc., et al., Iss. 1, Nov. 1999, p20*

Gene mutation may be linked to family PPH, Iss. 10, Aug. 2000, p21

New England medical journal apologizes for ethical lapse, Iss. 5, March 2000, p20

Redux, Meridia cause rat brain cell changes, researchers report, Iss. 5, March 2000, p20

Study causally links fenfluramines, PPH, Iss. 6, April 2000, p23

Study examines mechanism of arterial contraction from dexfenfluramine exposure, Iss. 12, Oct. 2000, p18

Study finds anorectics, including ‘Phen’ not linked to birth defects, Iss. 9, July 2000, p20

Study finds no heart damage in mice exposed to diet drugs in womb, Iss. 12, Oct. 2000, p18

Study finds ‘usual’ doses of Dexfenfluramine may not cause PPH, Iss. 2, Dec. 1999, p19

Study links diet drugs to aortic, but not mitral valve damage, serious events, Iss. 6, April 2000, p22

Study: Meridia protects against brain chemistry deficits of dexfenfluramine, Iss. 12, Oct. 2000, p17

Study says stethoscopes, not echocardiograms, should screen Redux users, Iss. 12, Oct. 2000, p16

AIDING and ABETTING

Lawsuits mount opposing AHP, Warner-Lambert merger, Iss. 2, Dec. 1999, p17

ALTERNATIVE DISPUTE RESOLUTION

Brown, Sheila et al. v. American Home Products, Iss. 1, Nov. 1999, p3A*; Iss. 2, Dec. 1999, p3C,D

In Re: Diet Drug Litigation, Iss. 7, May 2000, p6C

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 2, Dec. 1999, p3C,D

AMINOREX

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 8, June 2000, p13C

ANOREXIGENS

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 1, Nov. 1999, p18E

ANTAGONISTIC TOLERABILITY

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 9, July 2000, p6B

APPETITE SUPPRESSANTS

3 new medical studies indicate valve damage may regress or not worsen, Iss. 2, Dec. 1999, p18

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 1, Nov. 1999, p18E; Iss. 1, Nov. 1999, p19D

Linnen, Thomas F. et al. v. A.H. Robins Co., Inc., et al., Iss. 3, Jan. 2000, p5B,C

Wilson, Sheila et al. v. Biofarma S.A. and Servier Canada, Inc., Iss. 12, Oct. 2000, p13C*

ARBITRATION

In Re: New York Diet Drug Litigation, Iss. 2, Dec. 1999, p16H

ASBESTOS

Brown, Sheila et al. v. American Home Products, Iss. 1, Nov. 1999, p3A*; Iss. 4, Feb. 2000, p10*; Iss. 6, April 2000, p8C; Iss. 7, May 2000, p10; Iss. 11, Sept. 2000, p4A

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 4, Feb. 2000, p10*; Iss. 6, April 2000, p8C; Iss. 7, May 2000, p10; Iss. 11, Sept. 2000, p4A

Petito, Joseph et al. v. A.H. Robins Co. Inc., Iss. 3, Jan. 2000, p8A

ASYMPTOMATIC CONDITIONS

3 new medical studies indicate valve damage may regress or not worsen, Iss. 2, Dec. 1999, p18

336,344 responses received for settlement, Iss. 10, Aug. 2000, p12

Brown, Sheila et al. v. American Home Products, Iss. 1, Nov. 1999, p3A*; Iss. 7, May 2000, p10; Iss. 11, Sept. 2000, p4A

Lamping, Teri et al. v. American Home Products Inc., et al., Iss. 4, Feb. 2000, p4C

Luce, Donna J. et al. v. Gate Pharmaceuticals, et al., Iss. 11, Sept. 2000, p16B

Proponents, opponents debate trial viability, settlement adequacy, Iss. 1, Nov. 1999, p11

ATTORNEY-CLIENT PRIVILEGE

In Re: Diet Drug Litigation v. American Home Products Corp., et al., Iss. 12, Oct. 2000, p12

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 3, Jan. 2000, p18G; Iss. 5, March 2000, p13

ATTORNEY FEES / COURT COSTS

Brown, Sheila et al. v. American Home Products, Iss. 1, Nov. 1999, p3A*; Iss. 2, Dec. 1999, p3A,B; Iss. 3, Jan. 2000, p10E,F; Iss. 4, Feb. 2000, p10*; Iss. 6, April 2000, p4B; Iss. 6, April 2000, p8C; Iss. 6, April 2000, p16; Iss. 10, Aug. 2000, p18; Iss. 11, Sept. 2000, p15

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 2, Dec. 1999, p3A,B; Iss. 3, Jan. 2000, p10E,F; Iss. 4, Feb. 2000, p10*; Iss. 6, April 2000, p4B; Iss. 6, April 2000, p8C; Iss. 6, April 2000, p11; Iss. 6, April 2000, p16; Iss. 7, May 2000, p4B; Iss. 10, Aug. 2000, p18; Iss. 11, Sept. 2000, p15

Ludwig, Lawrence H. et al. v. American Home Products Corp., et al., Iss. 7, May 2000, p4B

Petition claims W.Va. judge voted for Medmon class to benefit husband’s firm, Iss. 7, May 2000, p8

In Re: Phen-Fen Litigation, Iss. 1, Nov. 1999, p21F

Proponents, opponents debate trial viability, settlement adequacy, Iss. 1, Nov. 1999, p11

BAD FAITH

Goddard-Lucero, Elizabeth D. v. American Home Products Corp., et al., Iss. 7, May 2000, p24A

BILLS

[See LEGISLATIVE NEWS / BILLS]

BLACK BOX WARNING

In Re: Diet Drug Litigation v. American Home Products Corp., et al., Iss. 12, Oct. 2000, p12

BREACH of CONTRACT

Interneuron Pharmaceuticals Inc v. American Home Products Corp., et al., Iss. 4, Feb. 2000, p8A

BREACH of FIDUCIARY DUTY

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 2, Dec. 1999, p8E,F

Fuller, Janet Lee, et al. v. Wyeth-Ayerst Laboratories et al., Iss. 2, Dec. 1999, p8E,F

Lawsuits mount opposing AHP, Warner-Lambert merger, Iss. 2, Dec. 1999, p17

BREACH of IMPLIED COVENANT of GOOD FAITH and FAIR DEALING

Interneuron Pharmaceuticals Inc v. American Home Products Corp., et al., Iss. 4, Feb. 2000, p8A

BREACH of WARRANY (EXPRESS / IMPLIED)

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 1, Nov. 1999, p14*; Iss. 3, Jan. 2000, p20*; Iss. 5, March 2000, p8D,E

EON Labs Manufacturing Inc. v. Reliance Insurance Co., et al., Iss. 10, Aug. 2000, p19A

List, Lloyd S. v. American Home Products Corp., et al., Iss. 3, Jan. 2000, p20*

Naumann, Barbara v. American Home Products Corp., et al., Iss. 3, Jan. 2000, p20*

In Re: Phen-Fen Litigation, Iss. 1, Nov. 1999, p21F

BREAST IMPLANTS

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 3, Jan. 2000, p15

In Re: Dow Corning Corp., Iss. 2, Dec. 1999, p14

Jeffers, Barbara et al. v. American Home Products Corp., Iss. 3, Jan. 2000, p15

CASE MANAGEMENT ORDER

In Re: Phen-Fen Litigation, Iss. 3, Jan. 2000, p18*

CAUSATION

Brown, Sheila et al. v. American Home Products Corp., Iss. 7, May 2000, p10; Iss. 8, June 2000, p4; Iss. 11, Sept. 2000, p4A

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 1, Nov. 1999, p18E; Iss. 1, Nov. 1999, p19D; Iss. 1, Nov. 1999, p20*; Iss. 3, Jan. 2000, p19*; Iss. 4, Feb. 2000, p13; Iss. 4, Feb. 2000, p20*; Iss. 5, March 2000, p16; Iss. 7, May 2000, p10; Iss. 8, June 2000, p4; Iss. 9, July 2000, p6B; Iss. 11, Sept. 2000, p4A

Dignan, JoAnne v. Gate Pharmaceuticals Inc., et al., Iss. 1, Nov. 1999, p20*

Haroutounian, Hermiah v. Wyeth-Ayerst Laboratories Co., Iss. 5, March 2000, p8A

LeBlanc, Pamela et al. v. St. Paul Fire and Marine Ins. Co., Iss. 12, Oct. 2000, p6*

Linnen, Thomas F. et al. v. A.H. Robins Co., Inc., et al., Iss. 3, Jan. 2000, p5B,C

Oran, Albert et al. v. John R. Stafford, et al., Iss. 11, Sept. 2000, p19*

Proponents, opponents debate trial viability, settlement adequacy, Iss. 1, Nov. 1999, p11

CLAIM SPLITTING

Brown, Sheila et al. v. American Home Products Corp., et al., Iss. 11, Sept. 2000, p4A

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 11, Sept. 2000, p4A

Lamping, Teri et al. v. American Home Products Inc., et al., Iss. 4, Feb. 2000, p4C

Luce, Donna J. et al. v. Gate Pharmaceuticals, et al., Iss. 11, Sept. 2000, p16B

CLASS ACTION

Interneuron stock settlement: $725,000, Iss. 4, Feb. 2000, p21

Brown, Sheila et al. v. American Home Products, Iss. 1, Nov. 1999, p3A*; Iss. 1, Nov. 1999, p3A*; Iss. 2,

Dec. 1999, p3C,D; Iss. 3, Jan. 2000, p10E,F; Iss. 3, Jan. 2000, p15D*; Iss. 3, Jan. 2000, p16; Iss. 4, Feb. 2000, p10*; Iss. 6, April 2000, p4B; Iss. 6, April 2000, p7D; Iss. 6, April 2000, p8C; Iss. 6, April 2000, p12; Iss. 6, April 2000, p13; Iss. 6, April 2000, p14*; Iss. 7, May 2000, p10; Iss. 7, May 2000, p22; Iss. 8, June 2000, p11A,B*; Iss. 9, July 2000, p12; Iss. 10, Aug. 2000, p7B; Iss. 11, Sept. 2000, p4A; Iss. 11, Sept. 2000, p12*; Iss. 11, Sept. 2000, p15; Iss. 12, Oct. 2000, p15

Burch, Margaret L. v. A.H. Robins Co. Inc., Iss. 5, March 2000, p7; Iss. 5, March 2000, p7

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 1, Nov. 1999, p14*; Iss. 1, Nov. 1999, p17C; Iss. 2, Dec. 1999, p3C,D; Iss. 3, Jan. 2000, p10E,F; Iss. 3, Jan. 2000, p15D*; Iss. 3, Jan. 2000, p16; Iss. 4, Feb. 2000, p10*; Iss. 4, Feb. 2000, p13; Iss. 4, Feb. 2000, p15; Iss. 5, March 2000, p8D,E; Iss. 5, March 2000, p13; Iss. 5, March 2000, p14; Iss. 5, March 2000, p15B; Iss. 6, April 2000, p4B; Iss. 6, April 2000, p7D; Iss. 6, April 2000, p8C; Iss. 6, April 2000, p12; Iss. 6, April 2000, p13; Iss. 6, April 2000, p14*; Iss. 7, May 2000, p10; Iss. 7, May 2000, p22; Iss. 8, June 2000, p11A,B*; Iss. 9, July 2000, p12; Iss. 9, July 2000, p15F; Iss. 10, Aug. 2000, p7B; Iss. 11, Sept. 2000, p4A; Iss. 11, Sept. 2000, p12*; Iss. 11, Sept. 2000, p15; Iss. 12, Oct. 2000, p15

Gonzalez, Lydia D. et al. v. Medeva Pharmaceuticals Inc., et al., Iss. 5, March 2000, p15B

Lamping, Teri et al. v. American Home Products Inc., et al., Iss. 4, Feb. 2000, p4C; Iss. 10, Aug. 2000, p4K

Lawsuits mount opposing AHP, Warner-Lambert merger, Iss. 2, Dec. 1999, p17

Lawyer complains about direct contact with clients about diet drug settlement, Iss. 5, March 2000, p14

Oran, Albert et al. v. John R. Stafford, et al., Iss. 11, Sept. 2000, p19*

Petition claims W.Va. judge voted for Medmon class to benefit husband’s firm, Iss. 7, May 2000, p8

Petito, Joseph et al. v. A.H. Robins Co. Inc., Iss. 3, Jan. 2000, p8A

Suits against AHP up 86% over 3 months, Iss. 2, Dec. 1999, p17

Texas judge reportedly favors national settlement, Iss. 9, July 2000, p17

Wilson, Sheila et al. v. Biofarma S.A. and Servier Canada, Inc., Iss. 12, Oct. 2000, p13C*

CLASS CERTIFICATION / DECERTIFICATION

Brown, Sheila et al. v. American Home Products, Iss. 1, Nov. 1999, p3A*; Iss. 2, Dec. 1999, p3A,B; Iss. 2, Dec. 1999, p3C,D; Iss. 3, Jan. 2000, p10E,F; Iss. 6, April 2000, p4B; Iss. 6, April 2000, p4B; Iss. 6, April 2000, p7D; Iss. 6, April 2000, p8C; Iss. 8, June 2000, p4; Iss. 9, July 2000, p12; Iss. 11, Sept. 2000, p4A; Iss. 11, Sept. 2000, p10

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 2, Dec. 1999, p3A,B; Iss. 2, Dec. 1999, p3C,D; Iss. 3, Jan. 2000, p10E,F; Iss. 5, March 2000, p8D,E; Iss. 5, March 2000, p14; Iss. 6, April 2000, p4B; Iss. 6, April 2000, p4B; Iss. 6, April 2000, p7D; Iss. 6, April 2000, p8C; Iss. 8, June 2000, p4; Iss. 9, July 2000, p12; Iss. 9, July 2000, p17E; Iss. 11, Sept. 2000, p4A; Iss. 11, Sept. 2000, p10

Jeffers, Barbara et al. v. American Home Products Corp., Iss. 1, Nov. 1999, p16*

Lamping, Teri et al. v. American Home Products Inc., et al., Iss. 4, Feb. 2000, p4C

Petition claims W.Va. judge voted for Medmon class to benefit husband’s firm, Iss. 7, May 2000, p8

Wish, Sharon v. Interneuron Pharmaceuticals Inc., Iss. 9, July 2000, p17E

CLASS NOTICE

Brown, Sheila et al. v. American Home Products, Iss. 1, Nov. 1999, p3A*; Iss. 2, Dec. 1999, p3C,D; Iss. 3, Jan. 2000, p10E,F; Iss. 3, Jan. 2000, p16; Iss. 8, June 2000, p4; Iss. 8, June 2000, p13; Iss. 10, Aug. 2000, p7B

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 2, Dec. 1999, p3C,D; Iss. 3, Jan. 2000, p10E,F; Iss. 3, Jan. 2000, p16; Iss. 8, June 2000, p4; Iss. 8, June 2000, p13; Iss. 10, Aug. 2000, p7B

COLLATERAL ESTOPPEL, DOCTRINE of

Brown, Sheila et al. v. American Home Products, Iss. 1, Nov. 1999, p3A*; Iss. 2, Dec. 1999, p3C,D; Iss. 10, Aug. 2000, p10I

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 2, Dec. 1999, p3C,D; Iss. 10, Aug. 2000, p10I

COMMON BENEFIT FUND / EQUITABLE ALLOCATION FUND DOCTRINE

Brown, Sheila et al. v. American Home Products, Iss. 1, Nov. 1999, p3A*; Iss. 6, April 2000, p16; Iss. 10, Aug. 2000, p18; Iss. 11, Sept. 2000, p15

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 3, Jan. 2000, p15; Iss. 5, March 2000, p18; Iss. 6, April 2000, p16; Iss. 6, April 2000, p20; Iss. 8, June 2000, p16*; Iss. 9, July 2000, p17; Iss. 10, Aug. 2000, p18; Iss. 11, Sept. 2000, p15

Falcone, Shirley Denise v. American Home Products, Corp., Iss. 9, July 2000, p17

Hala, Donna et ux v. American Home Products Corp., et al., Iss. 9, July 2000, p17

Gooch-Kiel, Lois v. American Home Products Corp., et al. Iss. 8, June 2000, p16*

Jeffers, Barbara et al. v. American Home Products Corp., Iss. 3, Jan. 2000, p15

Joiner, Perian et al. v. Wyeth-Ayerst Laboratories, et al., Iss. 5, March 2000, p15

COMPENSATION

Brown, Sheila et al. v. American Home Products, Iss. 1, Nov. 1999, p3A*; Iss. 6, April 2000, p7D; Iss. 8, June 2000, p4

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 5, March 2000, p8D,E; Iss. 6, April 2000, p7D; Iss. 8, June 2000, p4

Proponents, opponents debate trial viability, settlement adequacy, Iss. 1, Nov. 1999, p11

COMPENSATION MATRIX

336,344 responses received for settlement, Iss. 10, Aug. 2000, p12

Brinkley, Virginia v. American Home Products Corp., Iss. 5, March 2000, p4

Brown, Sheila et al. v. American Home Products Corp., Iss. 6, April 2000, p7D; Iss. 7, May 2000, p10; Iss. 8, June 2000, p4; Iss. 8, June 2000, p11A,B*; Iss. 10, Aug. 2000, p7B

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 1, Nov. 1999, p14*; Iss. 6, April 2000, p7D; Iss. 7, May 2000, p10; Iss. 8, June 2000, p4; Iss. 8, June 2000, p11A,B*; Iss. 10, Aug. 2000, p7B

Haroutounian, Hermineh v. Wyeth-Ayerst Laboratories Co., et al., Iss. 5, March 2000, p6

Kerr, Berle Dee et al. v. Wyeth-Ayerst Laboratories et al., Iss. 5, March 2000, p5

Proponents, opponents debate trial viability, settlement adequacy, Iss. 1, Nov. 1999, p11

CONFIDENTIALITY ORDERS

[See DISCOVERY, Confidentiality / Protective Orders]

CONFLICT of INTEREST

Brown, Sheila et al. v. American Home Products Corp., et al., Iss. 11, Sept. 2000, p10

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 4, Feb. 2000, p13; Iss. 11, Sept. 2000, p11

New England medical journal apologizes for ethical lapse, Iss. 5, March 2000, p20

Study finds anorectics, including ‘Phen’ not linked to birth defects, Iss. 9, July 2000, p20

CONSPIRACY

EON Labs Manufacturing Inc. v. Reliance Insurance Co., et al., Iss. 10, Aug. 2000, p19A

CONSTITUTIONAL ISSUES

Due Process

Brown, Sheila et al. v. American Home Products Corp., Iss. 8, June 2000, p4

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 8, June 2000, p4

Les Laboratories Servier, et al. v. Evelyn Wright, et al., Iss. 10, Aug. 2000, p5*

In Re: New York Diet Drug Litigation, Iss. 2, Dec. 1999, p16H

Eighth Amendment

American Home Products Corp. v. Oregon, Iss. 4, Feb. 2000, p17

Equal Protection

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 10, Aug. 2000, p15D,E,F

Fourth Amendment Rights

Brown, Sheila et al. v. American Home Products Corp., et al., Iss. 11, Sept. 2000, p10; Iss. 11, Sept. 2000, p12*

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 11, Sept. 2000, p10; Iss. 11, Sept. 2000, p12*

CONSUMER PROTECTION

Interneuron Pharmaceuticals Inc v. American Home Products Corp., et al., Iss. 4, Feb. 2000, p8A

CONTINUOUS TREATMENT DOCTRINE

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 10, Aug. 2000, p15D,E,F

CONTRACT

Brown, Sheila et al. v. American Home Products, Iss. 1, Nov. 1999, p3A*; Iss. 2, Dec. 1999, p3C,D

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 2, Dec. 1999, p3C,D; Iss. 6, April 2000, p11

CORPORATE NEWS

Caseload Status

415 suits filed in 40 days, Iss. 7, May 2000, p25

AHP diet drug suits increase by 22 percent, Iss. 6, April 2000, p20

Celltech reports 4,595 phentermine lawsuits, Iss. 11, Sept. 2000, p20

Interneuron suits up 9%, company says, Iss. 11, Sept. 2000, p19

Turkish researchers see lung problem from ‘Dex’ in laboratory rats, Iss. 11, Sept. 2000, p20

Corporate Filings

AHP: Federal grand jury subpoenas documents about adverse events, Iss. 7, May 2000, p23

Interneuron pays $2.45 million to liability defense firms, Iss. 8, June 2000, p18

Lawsuits mount opposing AHP, Warner-Lambert merger, Iss. 2, Dec. 1999, p17

Mergers and Acquisitions

Lawsuits mount opposing AHP, Warner-Lambert merger, Iss. 2, Dec. 1999, p17

DAMAGES

Lamping, Teri et al. v. American Home Products Inc., et al., Iss. 4, Feb. 2000, p4C

Luce, Donna J. et al. v. Gate Pharmaceuticals, et al., Iss. 11, Sept. 2000, p16B

Petito, Joseph et al. v. A.H. Robins Co. Inc., Iss. 3, Jan. 2000, p8A

Compensatory (General or Actual) Damages

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 7, May 2000, p24A

Goddard-Lucero, Elizabeth D. v. American Home Products Corp., et al., Iss. 7, May 2000, p24A

Washington et al. v. American Home Products Corp., Iss. 3, Jan. 2000, p4

Non-Economic Damages

Baston, Juanita v. American Home Products Corp., Iss. 9, July 2000, p4A*

Wirt, Richard v. American Home Products Corp., Iss. 9, July 2000, p4A*

Punitive (Exemplary) Damage

American Home Products Corp. v. Oregon, Iss. 4, Feb. 2000, p17

Baston, Juanita v. American Home Products Corp., Iss. 9, July 2000, p4A*

Brown, Sheila et al. v. American Home Products, Iss. 1, Nov. 1999, p3A*; Iss. 2, Dec. 1999, p3A,B; Iss. 2, Dec. 1999, p3C,D; Iss. 6, April 2000, p7D; Iss. 7, May 2000, p10; Iss. 7, May 2000, p22; Iss. 8, June 2000, p4

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 2, Dec. 1999, p3A,B; Iss. 2, Dec. 1999, p3C,D; Iss. 5, March 2000, p8D,E; Iss. 6, April 2000, p7D; Iss. 7, May 2000, p10; Iss. 7, May 2000, p22; Iss. 7, May 2000, p24A; Iss. 8, June 2000, p4

Goddard-Lucero, Elizabeth D. v. American Home Products Corp., et al., Iss. 7, May 2000, p24A

Lamping, Teri et al. v. American Home Products Corp., et al., Iss. 10, Aug. 2000, p4K

In Re: Phen-Fen Litigation, Iss. 1, Nov. 1999, p21F

Washington et al. v. American Home Products Corp., Iss. 3, Jan. 2000, p4

Wirt, Richard v. American Home Products Corp., Iss. 9, July 2000, p4A*

DAUBERT ISSUES

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 1, Nov. 1999, p17; Iss. 1, Nov. 1999, p18E; Iss. 1, Nov. 1999, p19D; Iss. 3, Jan. 2000, p19*; Iss. 4, Feb.

2000, p20*; Iss. 8, June 2000, p13C; Iss. 9, July 2000, p6B; Iss. 12, Oct. 2000, p14*

DEFAULT JUDGMENT

Damiani, Sharon et al. v. American Home Products Corp., et al., Iss. 7, May 2000, p4

Daniels, Gail L. et al. v. American Home Products Corp., et al., Iss. 7, May 2000, p4

DEFECTIVE DESIGN / PRODUCT

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 1, Nov. 1999, p18E; Iss. 1, Nov. 1999, p19D: Iss. 1, Nov. 1999, p20*; Iss. 10, Aug. 2000, p15D,E,F

Dignan, JoAnne v. Gate Pharmaceuticals Inc., et al., Iss. 1, Nov. 1999, p20*

In Re: Phen-Fen Litigation, Iss. 1, Nov. 1999, p21F

DEXFENFLURAMINE / REDUX

3 new medical studies indicate valve damage may regress or not worsen, Iss. 2, Dec. 1999, p18

AHP denies promoting Pondimin, withholding adverse event information, Iss. 10, Aug. 2000, p21

AHP: Federal grand jury subpoenas documents about adverse events, Iss. 7, May 2000, p23

AHP: Study says aortic ‘regurg’ unchanged, may improve; mitral unchanged, Iss. 9, July 2000, p19

In Re: American Home Products Corp., Iss. 4, Feb. 2000, p17

Brown, Sheila et al. v. American Home Products, Iss. 1, Nov. 1999, p3A*; Iss. 1, Nov. 1999, p3A*; Iss. 2,

Dec. 1999, p3A,B,; Iss. 7, May 2000, p10; Iss. 8, June 2000, p4; Iss. 11, Sept. 2000, p4A; Iss. 11, Sept. 2000, p15

Collins, Eileen S. et al. v. American Home Products Corp., et al., Iss. 5, March 2000, p17C

Damiani, Sharon et al. v. American Home Products Corp., et al., Iss. 7, May 2000, p4

Daniels, Gail L. et al. v. American Home Products Corp., et al., Iss. 7, May 2000, p4

Dexfenfluramine elevates blood pressure, study says, Iss. 5, March 2000, p20

In Re: Diet Drug Litigation v. American Home Products Corp., et al., Iss. 12, Oct. 2000, p12

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 1, Nov.

1999, p18E; Iss. 1, Nov. 1999, p19D: Iss. 1, Nov. 1999, p20*; Iss. 2, Dec. 1999, p3A,B; Iss. 2, Dec. 1999, p8E,F; Iss. 3, Jan. 2000, p18G; Iss. 4, Feb. 2000, p13; Iss. 4, Feb. 2000, p20*; Iss. 5, March 2000, p17C; Iss. 7, May 2000, p10; Iss. 8, June 2000, p4; Iss. 8, June 2000, p13C; Iss. 9, July 2000, p17E; Iss. 11, Sept. 2000, p4A; Iss. 11, Sept. 2000, p15

Dignan, JoAnne v. Gate Pharmaceuticals Inc., et al., Iss. 1, Nov. 1999, p20*

EON Labs Manufacturing Inc. v. Reliance Insurance Co., et al., Iss. 10, Aug. 2000, p19A

Fla. plaintiffs’ firm wins 15 remand; sales rep properly names, Iss. 3, Jan. 2000, p17

Fuller, Janet Lee, et al. v. Wyeth-Ayerst Laboratories et al., Iss. 2, Dec. 1999, p8E,F

Gene mutation may be linked to family PPH, Iss. 10, Aug. 2000, p21

Haroutounian, Hermiah v. Wyeth-Ayerst Laboratories Co., Iss. 5, March 2000, p8A

Hawthorne, Adelia v. American Home Products Corp., et al., Iss. 10, Aug. 2000, p3C

Interneuron Pharmaceuticals Inc v. American Home Products Corp., et al., Iss. 4, Feb. 2000, p8A

Interneuron settles securities litigation, Iss. 3, Jan. 2000, p21

Kerr, Berle Dee et al. v. Wyeth-Ayerst Laboratories et al., Iss. 5, March 2000, p5

Kohl, Patricia A. v. American Home Products Corp., et al., Iss. 4, Feb. 2000, p16*

Magures, Marvin v. American Home Products Corp., Iss. 10, Aug. 2000, p3

Lamping, Teri et al. v. American Home Products Inc., et al., Iss. 4, Feb. 2000, p4C

Luce, Donna J. et al. v. Gate Pharmaceuticals et al., Iss. 4, Feb. 2000, p6B

In Re: New York Diet Drug Litigation, Iss. 2, Dec. 1999, p16H

Oran, Albert et al. v. John R. Stafford, et al., Iss. 11, Sept. 2000, p19*

Perry, Sandra v. American Home Products Corp., et al., Iss. 12, Oct. 2000, p4

Proponents, opponents debate trial viability, settlement adequacy, Iss. 1, Nov. 1999, p11

Redux, Meridia cause rat brain cell changes, researchers report, Iss. 5, March 2000, p20

Rollins, Dorothy et al. v. American Home Products Corp., et al., Iss. 7, May 2000, p6

Study finds ‘usual’ doses of Dexfenfluramine may not cause PPH, Iss. 2, Dec. 1999, p19

Study: Meridia protects against brain chemistry deficits of dexfenfluramine, Iss. 12, Oct. 2000, p17

Suits against AHP up 86% over 3 months, Iss. 2, Dec. 1999, p17

Wish, Sharon v. Interneuron Pharmaceuticals Inc., Iss. 9, July 2000, p17E

DIRECTED VERDICT

Washington et al. v. American Home Products Corp., Iss. 3, Jan. 2000, p4

DISCOVERY

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 1, Nov. 1999, p17C; Iss. 3, Jan. 2000, p18G

Admissibility of Documents

In Re: Diet Drug Litigation v. American Home Products Corp., et al., Iss. 12, Oct. 2000, p12

Confidentiality / Protective Order

Brown, Sheila et al. v. American Home Products Corp., Iss. 4, Feb. 2000, p10*; Iss. 6, April 2000, p12; Iss. 7, May 2000, p10; Iss. 11, Sept. 2000, p15

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 4, Feb. 2000, p10*; Iss. 4, Feb. 2000, p15; Iss. 5, March 2000, p13; Iss. 5, March 2000, p18F; Iss. 6, April 2000, p12; Iss. 7, May 2000, p10; Iss. 9, July 2000, p17; Iss. 11, Sept. 2000, p15

Falcone, Shirley Denise v. American Home Products, Corp., Iss. 9, July 2000, p17

Hala, Donna et ux v. American Home Products Corp., et al., Iss. 9, July 2000, p17

Discovery Abuse

Damiani, Sharon et al. v. American Home Products Corp., et al., Iss. 7, May 2000, p4

Daniels, Gail L. et al. v. American Home Products Corp., et al., Iss. 7, May 2000, p4

In Camera Review

Brown, Sheila et al. v. American Home Products Corp., Iss. 7, May 2000, p10

In Re: Diet Drug Litigation v. American Home Products Corp., et al., Iss. 12, Oct. 2000, p12

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 3, Jan. 2000, p18G; Iss. 5, March 2000, p13; Iss. 7, May 2000, p10

Injunction

Brown, Sheila et al. v. American Home Products Corp., et al., Iss. 11, Sept. 2000, p15

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 6, April 2000, p13; Iss. 11, Sept. 2000, p15

Privilege Log

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 3, Jan. 2000, p18G

Restraining Order

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 6, April 2000, p13

Subpoena

AHP: Federal grand jury subpoenas documents about adverse events, Iss. 7, May 2000, p23

DISEASES / CONDITIONS

Congenital Heart Disease / Defect

Linnen, Thomas F. et al. v. A.H. Robins Co., Inc., et al., Iss. 3, Jan. 2000, p5B,C

Cirrhosis

Linnen, Thomas F. et al. v. A.H. Robins Co., Inc., et al., Iss. 3, Jan. 2000, p5B,C

Connective Tissue Disease

Linnen, Thomas F. et al. v. A.H. Robins Co., Inc., et al., Iss. 3, Jan. 2000, p5B,C

Creutzfeldt-Jakob Disease

Rollins, Dorothy et al. v. American Home Products Corp., et al., Iss. 7, May 2000, p6

Endocardial Fibrosis

Brown, Sheila et al. v. American Home Products, Iss. 1, Nov. 1999, p3A*

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 2, Dec. 1999, p3E,F; Iss. 4, Feb. 2000, p20*

Fuller, Janet Lee, et al. v. Wyeth-Ayerst Laboratories et al., Iss. 2, Dec. 1999, p8E,F

Endocarditis

3 new medical studies indicate valve damage may regress or not worsen, Iss. 2, Dec. 1999, p18

Endomyocardial Fibrosis

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 4, Feb. 2000, p20*

Grave’s Disease

LeBlanc, Pamela et al. v. St. Paul Fire and Marine Ins. Co., Iss. 12, Oct. 2000, p6*

Heart Murmur

3 new medical studies indicate valve damage may regress or not worsen, Iss. 2, Dec. 1999, p18

Study says stethoscopes, not echocardiograms, should screen Redux users, Iss. 12, Oct. 2000, p16

Heart Valve Regurgitation

3 new medical studies indicate valve damage may regress or not worsen, Iss. 2, Dec. 1999, p18

AHP: Study says aortic ‘regurg’ unchanged, may improve; mitral unchanged, Iss. 9, July 2000, p19

Brown, Sheila et al. v. American Home Products, Iss. 1, Nov. 1999, p3A*; Iss. 6, April 2000, p12; Iss. 7, May 2000, p10; Iss. 8, June 2000, p4

In Re: Diet Drug Litigation, Iss. 7, May 2000, p6C

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 2, Dec. 1999, p3E,F; Iss. 4, Feb. 2000, p13; Iss. 5, March 2000, p8D,E; Iss. 6, April 2000, p12; Iss. 7, May 2000, p10; Iss. 8, June 2000, p4

Fuller, Janet Lee, et al. v. Wyeth-Ayerst Laboratories et al., Iss. 2, Dec. 1999, p8E,F

Kerr, Berle Dee et al. v. Wyeth-Ayerst Laboratories et al., Iss. 5, March 2000, p5

Proponents, opponents debate trial viability, settlement adequacy, Iss. 1, Nov. 1999, p11

Human Immunodeficiency Virus (HIV)

Linnen, Thomas F. et al. v. A.H. Robins Co., Inc., et al., Iss. 3, Jan. 2000, p5B,C

Immune Complex Disease

Linnen, Thomas F. et al. v. A.H. Robins Co., Inc., et al., Iss. 3, Jan. 2000, p5B,C

Lung Cancer

Study finds ‘usual’ doses of Dexfenfluramine may not cause PPH, Iss. 2, Dec. 1999, p19

Mitral Valve Prolapse

Perry, Sandra v. American Home Products Corp., et al., Iss. 12, Oct. 2000, p4

Neurological Injury

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 4, Feb. 2000, p13

Neurotoxicity

Brown, Sheila et al. v. American Home Products Corp., Iss. 7, May 2000, p10; Iss. 8, June 2000, p4

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 1, Nov. 1999, p18E; Iss. 1, Nov. 1999, p19D: Iss. 1, Nov. 1999, p20*; Iss. 2, Dec. 1999, p8E,F; Iss. 5, March 2000, p8D,E; Iss. 7, May 2000, p10; Iss. 8, June 2000, p4

Dignan, JoAnne v. Gate Pharmaceuticals Inc., et al., Iss. 1, Nov. 1999, p20*

Fuller, Janet Lee, et al. v. Wyeth-Ayerst Laboratories et al., Iss. 2, Dec. 1999, p8E,F

Lamping, Teri et al. v. American Home Products Inc., et al., Iss. 4, Feb. 2000, p4C

Primary Pulmonary Hypertension (PPH)

Baston v. American Home Products Corp., Iss. 8, June 2000, p13; Iss. 9, July 2000, p4A*

Buol, Patricia v. A.H. Robins Co. Inc., et al., Iss. 6, April 2000, p4

Brown, Sheila et al. v. American Home Products, Iss. 1, Nov. 1999, p3A*; Iss. 2, Dec. 1999, p3C,D; Iss. 7, May 2000, p10; Iss. 8, June 2000, p4; Iss. 9, July 2000, p12C; Iss. 11, Sept. 2000, p4A

In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 1, Nov. 1999, p18E; Iss. 1, Nov. 1999, p19D: Iss. 1, Nov. 1999, p20*; Iss. 2, Dec. 1999, p3C,D; Iss. 2, Dec. 1999, p13; Iss. 4, Feb. 2000, p20*; Iss. 5, March 2000, p8D,E; Iss. 7, May 2000, p10; Iss. 7, May 2000, p24A; Iss. 8, June 2000, p4; Iss. 8, June 2000, p13C; Iss. 8, June 2000, p16*; Iss. 9, July 2000, p6B; Iss. 9, July 2000, p12C; Iss. 10, Aug. 2000, p15G,H; Iss. 10, Aug. 2000, p15D,E,F; Iss. 11, Sept. 2000, p4A; Iss. 12, Oct. 2000, p14*

Damiani, Sharon et al. v. American Home Products Corp., et al., Iss. 7, May 2000, p4

Daniels, Gail L. et al. v. American Home Products Corp., et al., Iss. 7, May 2000, p4

In Re: Diet Drug Litigation, Iss. 7, May 2000, p6C

Dignan, JoAnne v. Gate Pharmaceuticals Inc., et al., Iss. 1, Nov. 1999, p20*

Gene mutation may be linked to family PPH, Iss. 10, Aug. 2000, p21

Gilmore v. American Home Products, Iss. 2, Dec. 1999, p13

Goddard-Lucero, Elizabeth D. v. American Home Products Corp., et al., Iss. 7, May 2000, p24A

Gooch-Kiel, Lois v. American Home Products Corp., et al. Iss. 8, June 2000, p16*

Haroutounian, Hermiah v. Wyeth-Ayerst Laboratories Co., Iss. 5, March 2000, p8A

Hawthorne, Adelia v. American Home Products Corp., et al., Iss. 10, Aug. 2000, p3C

Kerr, Berle Dee et al. v. Wyeth-Ayerst Laboratories et al., Iss. 5, March 2000, p5

Lamping, Teri et al. v. American Home Products Inc., et al., Iss. 4, Feb. 2000, p4C

Linnen, Thomas F. et al. v. A.H. Robins Co., Inc., et al., Iss. 3, Jan. 2000, p5B,C; Iss. 4, Feb. 2000, p3*

Luce, Donna J. et al. v. Gate Pharmaceuticals et al., Iss. 4, Feb. 2000, p6B

Magures, Marvin v. American Home Products Corp., Iss. 10, Aug. 2000, p3

Nicol v. American Home Products Corp., Iss. 6, April 2000, p4

In Re: Phen-Fen Litigation, Iss. 7, May 2000, p8

Plummer, Julie v. A.H. Robins Co., Inc., et al., Iss. 6, April 2000, p4

Rocha, Esmeralda v. A.H. Robins, Iss. 2, Dec. 1999, p13

Scott, Shirley v. J.C. Penney, et al., Iss. 5, March 2000, p4

Study finds ‘usual’ doses of Dexfenfluramine may not cause PPH, Iss. 2, Dec. 1999, p19

Tufteland, Jerry v. Wyeth-Ayerst Laboratories, Iss. 2, Dec. 1999, p13

Washington et al. v. American Home Products Corp., Iss. 3, Jan. 2000, p4

Wirt, Richard v. American Home Products Corp., Iss. 9, July 2000, p4A*

Pulmonary Hypertension

3 new medical studies indicate valve damage may regress or not worsen, Iss. 2, Dec. 1999, p18

In Re: Diet Drugs (Phentermine/Fe